Pasithea Therapeutics CORP. (KTTAW) — DEF 14A Filings
All DEF 14A filings from Pasithea Therapeutics CORP.. Browse 3 Proxy Statement reports with AI-powered summaries and risk analysis.
DEF 14A Filings (3)
-
Pasithea Seeks 400% Boost in Authorized Shares, Fuels Incentive Plan
— Dec 29, 2025 Risk: high
Pasithea Therapeutics Corp. (KTTAW) is seeking stockholder approval to significantly increase its authorized common stock from 100,000,000 shares to 500,000,000 -
Pasithea Proposes 670% Stock Plan Boost, Reverse Split Ahead of Annual Meeting
— Jul 24, 2025 Risk: high
Pasithea Therapeutics Corp. (KTTAW) has filed a DEF 14A for its Annual Meeting on September 3, 2025, proposing several key changes. The company seeks to elect d -
Pasithea Therapeutics Files Proxy Statement
— May 28, 2024 Risk: low
Pasithea Therapeutics Corp. filed a definitive proxy statement (DEF 14A) on May 28, 2024, for its annual meeting on June 26, 2024. The company, incorporated in
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX